TIVC (Tivic Health Systems) רווח נקי למניה (EPS TTM)

Tivic Health Systems generates revenue through the sale of ClearUP bioelectronic systems, although the business is currently undergoing a phase of adaptation and cost optimization to achieve break-even. The trailing 12-month EPS on the GURU.Markets chart reflects profit dynamics, where the value -9.36 represents the most recent figure. Management is focusing on scaling the retail segment and implementing portable medical innovations.

This indicator reflects the rolling annual net income per share, excluding the impact of one-time accounting adjustments. For Tivic Health Systems (TIVC), this metric demonstrates the efficiency of scaling medical device sales. Analyzing the annual net income per share trend reveals a decrease in unit costs as volumes grow. This price action confirms that the business has reached a profitability plateau, allowing investors to objectively assess the asset's real value.